Support the development, deployment, and continuous effectiveness of enterprise EHS management systems across diverse regulatory jurisdictions, including Europe and the USA, aligned with ISO 14001, ISO 45001, PSCI principles and internal governance standards.
• Serve as system owner for Global EHS policies, procedures, risk assessment, objectives, metrics, and management review processes
• Partner with site EHS and operations teams to embed EHS systems into daily activities across GMP manufacturing, utilities, laboratories, and support functions
• Develop and maintain the global annual EHSS audit program and lead EHS audits, self-assessments, and gap analyses across sites and vendors
• Track findings, drive timely CAPA closure, and assess effectiveness to reduce systemic risk
• Establish and maintain global EHS metrics, dashboards, and reporting processes
• Provide data-driven insights to support governance forums and management reviews
• Drive EHS system maturity through continuous improvement and structured root cause analysis
• Support change management to ensure adoption, sustainability, and cultural integration
• Coach site EHS professionals and operational leaders on management system requirements and best practices
• Influence senior stakeholders to strengthen accountability for EHS performance
• Contribute to the development of EHS training materials, guidance documents, and standards
• 7–10 years’ experience in EHS, management systems, or compliance roles within
biopharmaceutical or regulated manufacturing environments
• Bachelor’s degree in EHS, Engineering, Science or related discipline
• Demonstrated experience implementing EHS management systems and planning and
leading audits and inspections. Formal ISO14001 / 45001 audit training or certification.
Preferred Qualifications
• Master’s degree in EHS, Engineering, Science or related discipline
• ISO 14001 / ISO 45001 Lead Auditor certification and experience with PSCI principles.
• Experience across multiple sites or global organizations
• Training in risk management, root cause analysis, or change management.
• Strong understanding of GMP environments and EHS–Quality system interfaces.
Skills & Behaviours
• Deep knowledge of EHS management systems, audits, CAPA, and performance
reporting. Familiarity with Pharmaceutical in the Supply Chain (PSCI) principles.
• Strong stakeholder influence, clear communication, and risk-based decision making
• Proactive, detail-oriented, collaborative, and resilient in regulated environments
Working Conditions
• Hybrid and/or site-based working model
• Travel expected: approximately 10–20%, primarily to manufacturing sites across
different jurisdictions, including Europe and the USA

At Alkermes, we apply our deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders. Our patient-inspired science, integrated research strategy, sophisticated development capabilities and specialized commercial infrastructure enable us to pursue the development and commercialization of innovative new medicines, including those for people with conditions that have traditionally been overlooked or stigmatized.
Our greatest strengths at Alkermes are our people and our inherent empathy for patients, families and caregivers. Neurological and psychiatric disorders strike people at the core of who they are and impact many facets of their lives. We work with urgency to develop new treatment options for people living with these conditions.
Beyond our important mission of developing medicines, we believe it is our responsibility to take a holistic approach as we seek to support patients, caregivers and broader impacted communities. We remain committed to patient engagement, responsible and sustainable operations, and equitable access to quality treatment.
Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio.
See our Community Guidelines: https://www.alkermes.com/social-community-guidelines